# OnCo record nct06488378 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06488378/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06488378", "NCT06488378" ;
  schema:name "Axatilimab and olaparib in BRCA/PALB2-associated metastatic breast cancer"@en ;
  schema:description "This early study combines a DNA-repair drug with a treatment targeting macrophages in advanced breast cancer. It is recruiting, with strict lung-history requirements."@en ;
  schema:url <https://onco.cc/trials/nct06488378/> ;
  schema:dateModified "2026-10-10"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06488378> ;
  onco:status "recruiting" ;
  onco:phase "1" ;
  schema:startDate "2024-08-13" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/tnbc/> ;
  onco:targets <https://onco.cc/targets/parp/> ;
  onco:drugs <https://onco.cc/drugs/olaparib/>, <https://onco.cc/drugs/axatilimab/> .